REFERENCES
- Lander E S, Linton L M, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860–921, [PUBMED], [INFOTRIEVE], [CSA]
- Venter J C, Adams M D, Myers E W, et al. The sequence of the human genome. Science 2001; 291: 1304–51, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hirschhorn J N, Daly M J. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005; 6: 95–108, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Scriver C R, et al. The metabolic and molecular bases of inherited disease. 7th ed. McGraw-Hill, New York 1995
- Lohmueller K E, Pearce C L, Pike M, Lander E S, Hirschhorn J N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 177–82, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lieberman J A, Stroup T, McEvoy J, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209–23, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mueser K T, McGurk S R. Schizophrenia. Lancet 2004; 363: 2063–72, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sawa A, Snyder S H. Schizophrenia: diverse approaches to a complex disease. Science 2002; 296: 692–5, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Harrison P J, Weinberger D R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; l10: 40–68, image 5[CROSSREF], [CSA]
- Gabriel S B, Schaffner S F, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cardon L R, Abecasis G R. Using haplotype blocks to map human complex trait loci. Trends Genet 2003; 19: 135–40, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sachidanandam R, Weissman D, Schmidt S C, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409: 928–33, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Altshuler D, Brooks L, Chakravarti A, Collins F, Daly M, Connelly P. A haplotype map of the human genome. Nature 2005; 437: 1299–320, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Carlson C S, Eberle M A, Kruglyak L, Nickerson D A. Mapping complex disease loci in whole-genome association studies. Nature 2004; 429: 446–52, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chumakov I, Blumenfeld M, Guerassimenko O, et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A 2002; 99: 13675–80, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stefansson H, Sigurdsson E, Steinthorsdottir V, et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71: 877–92, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stefansson H, Sarginson J, Kong A, et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003; 72: 83–7, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stefansson H, Steinthorsdottir V, Thorgeirsson T E, Gulcher J R, Stefansson K. Neuregulin 1 and schizophrenia. Ann Med 2004; 36: 62–71, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Petryshen T L, Middleton F A, Kirby A, et al. Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol Psychiatry 2005; l10: 366–74, 328[CROSSREF], [CSA]
- Williams N M, Preece A, Spurlock G, et al. Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol Psychiatry 2003; 8: 485–7, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Corvin A P, Morris D W, McGhee K, et al. Confirmation and refinement of an “at-risk” haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the neuregulin-1 locus. Mol Psychiatry 2004; 9: 208–13, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yang J Z, Si T M, Ruan Y, et al. Association study of neuregulin 1 gene with schizophrenia. Mol Psychiatry 2003; 8: 706–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Li T, Stefansson H, Gudfinnsson E, et al. Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype. Mol Psychiatry 2004; 9: 698–704, [PUBMED], [INFOTRIEVE], [CSA]
- Zhao X, Shi Y, Tang J, et al. A case control and family based association study of the neuregulin1 gene and schizophrenia. J Med Genet 2004; 41: 31–4, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Thiselton D L, Webb B T, Neale B M, et al. No evidence for linkage or association of neuregulin-1 (NRG1) with disease in the Irish study of high-density schizophrenia families (ISHDSF). Mol Psychiatry 2004; l9: 777–83, image 729[CROSSREF], [CSA]
- Green E K, Raybould R, Macgregor S, et al. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch Gen Psychiatry 2005; 62: 642–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Novelli G, D'Apice M R. The strange case of the “lumper” lamin A/C gene and human premature ageing. Trends Mol Med 2003; 9: 370–5, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tang J X, Chen W Y, He G, et al. Polymorphisms within 5′ end of the neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population. Mol Psychiatry 2004; 9: 11–2, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Iwata N, Suzuki T, Ikeda M, et al. No association with the neuregulin 1 haplotype to Japanese schizophrenia. Mol Psychiatry 2004; 9: 126–7, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Falls D L. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 2003; 284: 14–30, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fischbach G D, Rosen K M. Aria: a neuromuscular junction neuregulin. Annu Rev Neurosci 1997; 20: 429–58, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hippenmeyer S, Shneider N A, Birchmeier C, Burden S J, Jessell T M, Arber S. A role for neuregulin1 signaling in muscle spindle differentiation. Neuron 2002; 36: 1035–49, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Javitt D C. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J Clin Psychiatry 1987; 9: 12–35, [PUBMED], [INFOTRIEVE], [CSA]
- Krystal J H, Karper L P, Seibyl J P, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994; 51: 199–214, [PUBMED], [INFOTRIEVE], [CSA]
- Ozaki M, Sasner M, Yano R, Lu H S, Buonanno A. Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 1997; 390: 691–4, [PUBMED], [INFOTRIEVE], [CSA]
- Gu Z, Jiang Q, Fuk A, Ip N, Yan Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J Neurosci 2005; 25: 4974–84, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Okada M, Corfas G. Neuregulin1 downregulates postsynaptic GABA A receptors at the hippocampal inhibitory synapse. Hippocampus 2004; 14: 337–44, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Xie F, Raetzman L T, Siegel R E. Neuregulin induces GABA A receptor beta2 subunit expression in cultured rat cerebellar granule neurons by activating multiple signaling pathways. J Neurochem 2004; 90: 1521–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Volk D W, Pierri J N, Fritschy J M, Auh S, Sampson A R, Lewis D A. Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex 2002; 12: 1063–70, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Volk D, Austin M, Pierri J, Sampson A, Lewis D. Gaba transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am J Psychiatry 2001; 158: 256–65, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lewis D A, Volk D W, Hashimoto T. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology (Berl) 2004; l174: 143–50, [CSA]
- Veldic M, Caruncho H J, Liu W S, et al. DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc Natl Acad Sci U S A 2004; 101: 348–53, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Freedman R, Leonard S, Gault J M, et al. Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7). Am J Med Genet 2001; 105: 20–2, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Freedman R, Adler L E, Bickford P, et al. Schizophrenia and nicotinic receptors. Harv Rev Psychiatry 1994; 2: 179–92, [PUBMED], [INFOTRIEVE], [CSA]
- Perl O, Ilani T, Strous R D, Lapidus R, Fuchs S. The alpha7 nicotinic acetylcholine receptor in schizophrenia: decreased mRNA levels in peripheral blood lymphocytes. FASEB J 2003; 17: 1948–50, [PUBMED], [INFOTRIEVE], [CSA]
- Liu Y, Ford B, Mann M A, Fischbach G D. Neuregulins increase alpha7 nicotinic acetylcholine receptors and enhance excitatory synaptic transmission in GABAergic interneurons of the hippocampus. J Neurosci 2001; 21: 5660–9, [PUBMED], [INFOTRIEVE], [CSA]
- Fleisig H, El-Din El-Husseini A, Vincent S R. Regulation of ErbB4 phosphorylation and cleavage by a novel histidine acid phosphatase. Neuroscience 2004; 127: 91–100, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vidal G A, Naresh A, Marrero L, Jones F E. Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities. J Biol Chem 2005; l280: 19777–83, Epub 2005 Mar 3[CROSSREF], [CSA]
- Bao J, Lin H, Ouyang Y, Lei D, Osman A, Kim T W, et al. Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and eos. Nat Neurosci 2004; 7: 1250–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fang M, Jaffrey S R, Sawa A, Ye K, Luo X, Snyder S H. Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron 2000; 28: 183–93, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Brzustowicz L M, Simone J, Mohseni P, et al. Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. Am J Hum Genet 2004; l74: 1057–63, [CROSSREF], [CSA]
- Pankonin M S, Gallagher J T, Loeb J A. Specific structural features of heparan sulfate proteoglycans potentiate neuregulin-1 signaling. J Biol Chem 2005; 280: 383–8, [PUBMED], [INFOTRIEVE], [CSA]
- Schmid R S, McGrath B, Berechid B E, et al. Neuregulin 1-erbB2 signaling is required for the establishment of radial glia and their transformation into astrocytes in cerebral cortex. Proc Natl Acad Sci U S A 2003; 100: 4251–6, [PUBMED], [INFOTRIEVE], [CSA]
- Anton E S, Ghashghaei H T, Weber J L, et al. Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain. Nat Neurosci 2004; 7: 1319–28, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rio C, Rieff H I, Qi P, Khurana T S, Corfas G. Neuregulin and ErbB receptors play a critical role in neuronal migration. Neuron 1997; 19: 39–50, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Miller S J, Li H, Rizvi T A, et al. Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis. Mol Cell Biol 2003; 23: 2213–24, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Patten B A, Peyrin J M, Weinmaster G, Corfas G. Sequential signaling through Notch1 and erbB receptors mediates radial glia differentiation. J Neurosci 2003; 23: 6132–40, [PUBMED], [INFOTRIEVE], [CSA]
- Yau H J, Wang H F, Lai C, Liu F C. Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences. Cereb Cortex 2003; 13: 252–64, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Millar J K, Wilson-Annan J C, Anderson S, et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000; 9: 1415–23, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lee W L, Oberle J R, Cooper J A. The role of the lissencephaly protein Pac1 during nuclear migration in budding yeast. J Cell Biol 2003; 160: 355–64, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Flames N, Long J E, Garratt A N, et al. Short- and long-range attraction of cortical gabaergic interneurons by neuregulin-1. Neuron 2004; 44: 251–61, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Moore C I. Frequency-dependent processing in the vibrissa sensory system. J Neurophysiol 2004; 91: 2390–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Deschenes M, Timofeeva E, Lavallee P. The relay of high-frequency sensory signals in the whisker-to-barreloid pathway. J Neurosci 2003; 23: 6778–87, [PUBMED], [INFOTRIEVE], [CSA]
- Ango F, di Cristo G, Higashiyama H, Bennett V, Wu P, Huang Z J. Ankyrin-based subcellular gradient of neurofascin, an immunoglobulin family protein, directs GABAergic innervation at purkinje axon initial segment. Cell 2004; l119: 257–72, [CROSSREF], [CSA]
- Gerecke K M, Wyss J M, Carroll S L. Neuregulin-1beta induces neurite extension and arborization in cultured hippocampal neurons. Mol Cell Neurosci 2004; 27: 379–93, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tabin C J, Bradley S M, Bargmann C I, et al. Mechanism of activation of a human oncogene. Nature 1982; 300: 143–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Shen Z X, Shi Z Z, Fang J, et al. All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A 2004; 101: 5328–35, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Marx J. Medicine. Why a new cancer drug works well, in some patients. Science 2004; 304: 658–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lynch T J, Bell D W, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004; 350: 2129–39, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Karasarides M, Chiloeches A, Hayward R, et al. B-raf is a therapeutic target in melanoma. Oncogene 2004; l23: 6292–8, [CROSSREF], [CSA]
- Heinrich M C, Corless C L, Demetri G D, et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2003; l21: 4342–9, [CROSSREF], [CSA]
- Cools J, De Angelo D J, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1l1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003; 348: 1201–14, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- St George-Hyslop P H, Petit A. Molecular biology and genetics of Alzheimer's disease. C R Biol 2005; 328: 119–30, [PUBMED], [INFOTRIEVE], [CSA]
- Wong P C, Cai H, Borchelt D R, Price D L. Genetically engineered mouse models of neurodegenerative diseases. Nat Neurosci 2002; 5: 633–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]